Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Harmony Biosciences Holdings (HRMY) Interest Expenses (2023 - 2025)

Harmony Biosciences Holdings' Interest Expenses history spans 3 years, with the latest figure at $3.5 million for Q4 2025.

  • For Q4 2025, Interest Expenses fell 15.75% year-over-year to $3.5 million; the TTM value through Dec 2025 reached $14.6 million, down 16.27%, while the annual FY2025 figure was $14.6 million, 16.27% down from the prior year.
  • Interest Expenses for Q4 2025 was $3.5 million at Harmony Biosciences Holdings, down from $3.6 million in the prior quarter.
  • Across five years, Interest Expenses topped out at $7.0 million in Q3 2023 and bottomed at $3.5 million in Q4 2025.
  • The 3-year median for Interest Expenses is $4.4 million (2024), against an average of $4.7 million.
  • The largest YoY upside for Interest Expenses was 12.24% in 2024 against a maximum downside of 37.99% in 2024.
  • A 3-year view of Interest Expenses shows it stood at $4.8 million in 2023, then decreased by 12.24% to $4.2 million in 2024, then dropped by 15.75% to $3.5 million in 2025.
  • Per Business Quant, the three most recent readings for HRMY's Interest Expenses are $3.5 million (Q4 2025), $3.6 million (Q3 2025), and $3.6 million (Q2 2025).